151 related articles for article (PubMed ID: 4070930)
1. Carcinogenicity testing of antitumor agents.
Hottendorf GH
Toxicol Pathol; 1985; 13(3):192-9. PubMed ID: 4070930
[TBL] [Abstract][Full Text] [Related]
2. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
3. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
Mitsumori K; Koizumi H; Nomura T; Yamamoto S
Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
[TBL] [Abstract][Full Text] [Related]
4. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
5. [The mutagenic and carcinogenic activity of chemical compounds].
Rakitskiĭ VN; Turusov VS
Vestn Ross Akad Med Nauk; 2005; (3):7-9. PubMed ID: 15852703
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
Zeiger E
Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity, carcinogenicity, and teratogenicity of acrylonitrile.
Léonard A; Gerber GB; Stecca C; Rueff J; Borba H; Farmer PB; Sram RJ; Czeizel AE; Kalina I
Mutat Res; 1999 May; 436(3):263-83. PubMed ID: 10354525
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and experimental applications to occupational cancer prevention.
Vainio H; Hemminki K
J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
[TBL] [Abstract][Full Text] [Related]
9. Testing of chemicals for carcinogenic activities and some problems related to the assessment of carcinogenic risks to men.
Schramm T; Teichmann B
Pol J Pharmacol Pharm; 1979; 31(6):639-45. PubMed ID: 550120
[TBL] [Abstract][Full Text] [Related]
10. Experimental investigations into the carcinogenic effect of antitumor and immunosuppressive agents.
Brock N; Schneider B; Stekar J; Pohl J
J Cancer Res Clin Oncol; 1989; 115(4):309-28. PubMed ID: 2760096
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of transplacental exposure into routine carcinogenicity bioassays.
Swenberg JA
Natl Cancer Inst Monogr; 1979 May; (51):265-8. PubMed ID: 481580
[TBL] [Abstract][Full Text] [Related]
12. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
Shirai T; Hirose M; Ito N
IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
[No Abstract] [Full Text] [Related]
13. Carcinogenicity, mutagenicity and teratogenicity of nickel.
Léonard A; Gerber GB; Jacquet P
Mutat Res; 1981 Jul; 87(1):1-15. PubMed ID: 7035928
[TBL] [Abstract][Full Text] [Related]
14. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays.
Paini A; Scholz G; Marin-Kuan M; Schilter B; O'Brien J; van Bladeren PJ; Rietjens IM
Mutagenesis; 2011 Sep; 26(5):605-18. PubMed ID: 21642616
[TBL] [Abstract][Full Text] [Related]
16. Failure of short-term in vitro mutagenicity tests to predict the animal carcinogenicity of hair dyes.
Burnett CM; Corbett JF
Food Chem Toxicol; 1987 Sep; 25(9):703-7. PubMed ID: 3653824
[TBL] [Abstract][Full Text] [Related]
17. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys.
Gold LS; Manley NB; Slone TH; Ward JM
Toxicol Pathol; 2001; 29(6):639-52. PubMed ID: 11794380
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenic, mutagenic, teratogenic workshop.
Suit H; Hall E; Frei E
Cancer Clin Trials; 1981; 4 Suppl():37-41. PubMed ID: 7307224
[No Abstract] [Full Text] [Related]
19. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
20. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database.
Gold LS; Slone TH; Ames BN
Drug Metab Rev; 1998 May; 30(2):359-404. PubMed ID: 9606609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
